androtriol (YC-6) / Guangzhou Cellprotek Pharmaceutical - LARVOL DELTA

A Phase IIa trial of Androtriol Injection for the Treatment of Intracerebral Hemorrhage: a Multicenter, Randomized, Double-blind, Placebo-controlled Study (ChiCTR) - P2 | N=105 | Sponsor: Xiangya Hospital of Central South University; Guangzhou Cellprotek Pharmaceutical CO, Ltd.

New P2 trial • Cerebral Hemorrhage • Hematological Disorders

A Phase IIa trial of Androtriol Injection for the Treatment of Acute Ischemic Stroke-a Prospective, Randomized, and Placebo-controlled Study (ChiCTR) - P2 | N=46 | Completed | Sponsor: The Army Medical Center of the Chinese People’s Liberation Army; Guangzhou Cellprotek Pharmaceutical CO., Ltd.

New P2 trial • Cardiovascular • Ischemic stroke